Sagol O - Search Results

1

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.

Culhaci N, Sagol O, Karademir S, Astarcioglu H, Astarcioglu I, Soyturk M, Oztop I, Obuz F. Culhaci N, et al. Among authors: sagol o. BMC Cancer. 2005 Aug 8;5:98. doi: 10.1186/1471-2407-5-98. BMC Cancer. 2005. PMID: 16086840 Free PMC article.

2

Endoscopic and histological characteristics of small bowel tumors diagnosed by double-balloon enteroscopy.

Dolu S, Onem S, Htway Z, Hajıyev F, Bilgen A, Binicier HC, Kalemoglu E, Sagol O, Akarsu M. Dolu S, et al. Among authors: sagol o. Clin Endosc. 2023 Jan;56(1):83-91. doi: 10.5946/ce.2022.131. Epub 2022 Oct 27. Clin Endosc. 2023. PMID: 36733990 Free PMC article.

3

Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver.

Özaslan E, Günşar F, Çiftçibaşı Örmeci A, Hatemi İ, Efe C, Akyol G, Turhan N, Barbet FY, Sağol Ö, Ataizi Çelikel Ç, Güllüoğlu M, Gökçe DT, İstemihan Z, Eşkazan T, İdilman R. Özaslan E, et al. Among authors: sagol o. Turk J Gastroenterol. 2023 Nov;34(Suppl2):S1-S33. doi: 10.5152/tjg.2023.23242. Turk J Gastroenterol. 2023. PMID: 37947207 Free article.

4

Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival.

Sagol O, Tuna B, Coker A, Karademir S, Obuz F, Astarcioglu H, Küpelioglu A, Astarcioglu I, Topalak O. Sagol O, et al. Pathol Res Pract. 2002;198(2):77-84. doi: 10.1078/0344-0338-00190. Pathol Res Pract. 2002. PMID: 11928868

5

Effect of ursodeoxycholic acid on hepatic steatosis in rats.

Okan A, Astarcioglu H, Tankurt E, Sagol O, Altekin E, Astarcioglu I, Gonen O. Okan A, et al. Among authors: sagol o. Dig Dis Sci. 2002 Nov;47(11):2389-97. doi: 10.1023/a:1020523017873. Dig Dis Sci. 2002. PMID: 12452368

6

Prognostic significance of mean nuclear volume in pancreatic adenocarcinoma.

Ozkal S, Sagol O, Karademir S, Coker A, Astarcioglu H, Küpelioglu A, Astarcioglu I, Topalak O, Göktay Y. Ozkal S, et al. Among authors: sagol o. Anal Quant Cytol Histol. 2003 Aug;25(4):221-6. Anal Quant Cytol Histol. 2003. PMID: 12961829

7

The effects of vascular bed expansion in steatotic rat liver graft viability.

Astarcioğlu H, Karademir S, Atila K, Sağol O, Koçdor H, Coker A, Astarcioğlu I. Astarcioğlu H, et al. Among authors: sagol o. Transpl Int. 2004 May;17(4):188-94. doi: 10.1007/s00147-004-0692-9. Epub 2004 Apr 24. Transpl Int. 2004. PMID: 15107972 Free article.

8

The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas.

Lebe B, Sağol O, Ulukuş C, Coker A, Karademir S, Astarcioglu H, Küpelioğlu A, Astarcioğlu I, Obuz F. Lebe B, et al. Among authors: sagol o. Pathol Res Pract. 2004;200(5):389-96. doi: 10.1016/j.prp.2004.02.010. Pathol Res Pract. 2004. PMID: 15239347

9

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M. Oztop I, et al. Among authors: sagol o. Chemotherapy. 2004 Jun;50(3):127-32. doi: 10.1159/000077886. Chemotherapy. 2004. PMID: 15282439 Clinical Trial.

10

Efficiency of MR imaging in the detection of malignant liver lesions.

Obuz F, Oksüzler M, Seçil M, Sağol O, Karademir S, Astarcioğlu H. Obuz F, et al. Among authors: sagol o. Diagn Interv Radiol. 2006 Mar;12(1):17-21. Diagn Interv Radiol. 2006. PMID: 16538579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page